NTx
Osteomark NTx Point-of-Care Device Testing 2001
February 2001, the Osteoporosis Education Project served
as one of four nationwide test sites for a clinical trial evaluating
the Osteomark NTx
Point-of-Care Device. The object of this clinical trial
was to see if the NTx measurement device could be self-administered
at home. This study was done in compliance with FDA requirements.
Principal investigators Nancy Mallinak, Ph.D. and Susan E. Brown,
Ph.D., CCN. This NTx
Point of Care Device has now been approved by the FDA and
is widely distributed.